Skip to main content
Top
Published in: Angiogenesis 1/2013

01-01-2013 | Original Paper

A novel role for inducible Fut2 in angiogenesis

Authors: Pei-Suen Tsou, Jeffrey H. Ruth, Phillip L. Campbell, Takeo Isozaki, SolHee Lee, Hubert Marotte, Steven E. Domino, Alisa E. Koch, Mohammad A. Amin

Published in: Angiogenesis | Issue 1/2013

Login to get access

Abstract

Rationale

Angiogenesis plays an important role in wound healing and tumor growth. Fucosyltransferases synthesize fucosylated glycans and may play a major role in vascular biology.

Objective

To examine the role of an alpha(1,2) fucosyltransferase (Fut2) in angiogenesis.

Methods and results

We found that Fut2 mRNA and protein expression is inducible in human dermal microvascular endothelial cells (HMVECs). After finding that Fut2 is inducible in HMVECs, we examined if Fut2 contributes to angiogenesis. We found that Fut2 null endothelial cell (EC) migration and tube formation were significantly less compared to wild type (wt) ECs. Angiogenesis was impaired in Fut2 null compared to wt mice in the mouse Matrigel plug and the sponge granuloma angiogenesis assays. To assess the characteristics of Fut2 null ECs in vivo, we performed Matrigel plug angiogenesis assays in wt mice using Fut2 null and wt mouse ECs. We found a significant decrease in Fut2 null EC incorporation in neoangiogenesis compared to wt ECs. ERK1/2 activation, fibroblast growth factor receptor2, and vascular endothelial growth factor expression were less in Fut2 null ECs, suggesting a possible mechanism of impaired angiogenesis when Fut2 is lacking.

Conclusions

These data suggest a novel role for Fut2 as a regulator of angiogenesis.
Literature
1.
go back to reference de Vries T, Knegtel RM, Holmes EH, Macher BA (2001) Fucosyltransferases: structure/function studies. Glycobiology 11(10):119R–128RPubMedCrossRef de Vries T, Knegtel RM, Holmes EH, Macher BA (2001) Fucosyltransferases: structure/function studies. Glycobiology 11(10):119R–128RPubMedCrossRef
2.
go back to reference Oriol R, Mollicone R, Coullin P, Dalix AM, Candelier JJ (1992) Genetic regulation of the expression of ABH and Lewis antigens in tissues. APMIS Suppl 27:28–38PubMed Oriol R, Mollicone R, Coullin P, Dalix AM, Candelier JJ (1992) Genetic regulation of the expression of ABH and Lewis antigens in tissues. APMIS Suppl 27:28–38PubMed
3.
go back to reference Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ (1995) Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376(6540):517–519. doi:10.1038/376517a0 PubMedCrossRef Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ (1995) Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376(6540):517–519. doi:10.​1038/​376517a0 PubMedCrossRef
4.
go back to reference Lowe JB (1997) Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney Int 51(5):1418–1426PubMedCrossRef Lowe JB (1997) Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney Int 51(5):1418–1426PubMedCrossRef
5.
go back to reference Moehler TM, Sauer S, Witzel M, Andrulis M, Garcia-Vallejo JJ, Grobholz R, Willhauck-Fleckenstein M, Greiner A, Goldschmidt H, Schwartz-Albiez R (2008) Involvement of alpha 1–2-fucosyltransferase I (FUT1) and surface-expressed Lewis(y) (CD174) in first endothelial cell–cell contacts during angiogenesis. J Cell Physiol 215(1):27–36PubMedCrossRef Moehler TM, Sauer S, Witzel M, Andrulis M, Garcia-Vallejo JJ, Grobholz R, Willhauck-Fleckenstein M, Greiner A, Goldschmidt H, Schwartz-Albiez R (2008) Involvement of alpha 1–2-fucosyltransferase I (FUT1) and surface-expressed Lewis(y) (CD174) in first endothelial cell–cell contacts during angiogenesis. J Cell Physiol 215(1):27–36PubMedCrossRef
6.
go back to reference Amin MA, Rabquer BJ, Kumar P, Mansfield PJ, Campbell PL, Domino SE, Koch AE (2007) A unique role for cytokine inducible fucosyltransferase 1 in angiogenesis. Arthritis Rheum 56:S583CrossRef Amin MA, Rabquer BJ, Kumar P, Mansfield PJ, Campbell PL, Domino SE, Koch AE (2007) A unique role for cytokine inducible fucosyltransferase 1 in angiogenesis. Arthritis Rheum 56:S583CrossRef
7.
go back to reference Nguyen M, Strubel NA, Bischoff J (1993) A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365:267–269PubMedCrossRef Nguyen M, Strubel NA, Bischoff J (1993) A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365:267–269PubMedCrossRef
8.
go back to reference Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB (1995) Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270(9):4640–4649PubMedCrossRef Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB (1995) Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270(9):4640–4649PubMedCrossRef
9.
go back to reference Rouquier S, Lowe JB, Kelly RJ, Fertitta AL, Lennon GG, Giorgi D (1995) Molecular cloning of a human genomic region containing the H blood group alpha(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem 270(9):4632–4639PubMedCrossRef Rouquier S, Lowe JB, Kelly RJ, Fertitta AL, Lennon GG, Giorgi D (1995) Molecular cloning of a human genomic region containing the H blood group alpha(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem 270(9):4632–4639PubMedCrossRef
10.
go back to reference Blackwell CC, Jonsdottir K, Hanson MF, Weir DM (1986) Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet 2(8508):687PubMedCrossRef Blackwell CC, Jonsdottir K, Hanson MF, Weir DM (1986) Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet 2(8508):687PubMedCrossRef
11.
go back to reference Blackwell CC, Jonsdottir K, Hanson M, Todd WT, Chaudhuri AK, Mathew B, Brettle RP, Weir DM (1986) Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet 2(8501):284–285PubMedCrossRef Blackwell CC, Jonsdottir K, Hanson M, Todd WT, Chaudhuri AK, Mathew B, Brettle RP, Weir DM (1986) Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet 2(8501):284–285PubMedCrossRef
12.
go back to reference Hiller KM, Mayben JP, Bendt KM, Manousos GA, Senger K, Cameron HS, Weston BW (2000) Transfection of alpha(1,3)fucosyltransferase antisense sequences impairs the proliferative and tumorigenic ability of human colon carcinoma cells. Mol Carcinog 27(4):280–288PubMedCrossRef Hiller KM, Mayben JP, Bendt KM, Manousos GA, Senger K, Cameron HS, Weston BW (2000) Transfection of alpha(1,3)fucosyltransferase antisense sequences impairs the proliferative and tumorigenic ability of human colon carcinoma cells. Mol Carcinog 27(4):280–288PubMedCrossRef
13.
go back to reference Palumberi D, Aldi S, Ermini L, Ziche M, Finetti F, Donnini S, Rosati F (2010) RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation. J Cell Biochem 111(1):229–238. doi:10.1002/jcb.22692 PubMedCrossRef Palumberi D, Aldi S, Ermini L, Ziche M, Finetti F, Donnini S, Rosati F (2010) RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation. J Cell Biochem 111(1):229–238. doi:10.​1002/​jcb.​22692 PubMedCrossRef
14.
go back to reference Domino SE, Zhang L, Gillespie PJ, Saunders TL, Lowe JB (2001) Deficiency of reproductive tract alpha(1,2)fucosylated glycans and normal fertility in mice with targeted deletions of the FUT1 or FUT2 alpha(1,2)fucosyltransferase locus. Mol Cell Biol 21(24):8336–8345PubMedCrossRef Domino SE, Zhang L, Gillespie PJ, Saunders TL, Lowe JB (2001) Deficiency of reproductive tract alpha(1,2)fucosylated glycans and normal fertility in mice with targeted deletions of the FUT1 or FUT2 alpha(1,2)fucosyltransferase locus. Mol Cell Biol 21(24):8336–8345PubMedCrossRef
15.
go back to reference Domino SE, Zhang L, Lowe JB (2001) Molecular cloning, genomic mapping, and expression of two secretor blood group alpha (1,2)fucosyltransferase genes differentially regulated in mouse uterine epithelium and gastrointestinal tract. J Biol Chem 276(26):23748–23756PubMedCrossRef Domino SE, Zhang L, Lowe JB (2001) Molecular cloning, genomic mapping, and expression of two secretor blood group alpha (1,2)fucosyltransferase genes differentially regulated in mouse uterine epithelium and gastrointestinal tract. J Biol Chem 276(26):23748–23756PubMedCrossRef
16.
go back to reference Marelli-Berg FM, Peek E, Lidington EA, Stauss HJ, Lechler RI (2000) Isolation of endothelial cells from murine tissue. J Immunol Methods 244:205–215PubMedCrossRef Marelli-Berg FM, Peek E, Lidington EA, Stauss HJ, Lechler RI (2000) Isolation of endothelial cells from murine tissue. J Immunol Methods 244:205–215PubMedCrossRef
17.
go back to reference Koch AE, Polverini PJ, Leibovich SJ (1986) Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum 29(4):471–479PubMedCrossRef Koch AE, Polverini PJ, Leibovich SJ (1986) Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum 29(4):471–479PubMedCrossRef
18.
go back to reference Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE (2003) Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 93(4):321–329PubMedCrossRef Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE (2003) Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 93(4):321–329PubMedCrossRef
19.
go back to reference Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE (2001) Evidence of IL-18 as a novel angiogenic mediator. J Immunol 167(3):1644–1653PubMed Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE (2001) Evidence of IL-18 as a novel angiogenic mediator. J Immunol 167(3):1644–1653PubMed
20.
go back to reference Fricke I, Mitchell D, Petersen F, Bohle A, Bulfone-Paus S, Brandau S (2004) Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells. FASEB J 18(13):1588–1590. doi:10.1096/fj.03-1435fje PubMed Fricke I, Mitchell D, Petersen F, Bohle A, Bulfone-Paus S, Brandau S (2004) Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells. FASEB J 18(13):1588–1590. doi:10.​1096/​fj.​03-1435fje PubMed
21.
go back to reference Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, Chun GT, Kim NS, Yie SW, Byeon WH, Eom SH, Ha KS, Kim YM, Kim PH (2007) Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol 81(2):557–566. doi:10.1189/jlb.0806517 PubMedCrossRef Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, Chun GT, Kim NS, Yie SW, Byeon WH, Eom SH, Ha KS, Kim YM, Kim PH (2007) Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol 81(2):557–566. doi:10.​1189/​jlb.​0806517 PubMedCrossRef
23.
go back to reference Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1(1):27–31PubMedCrossRef Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1(1):27–31PubMedCrossRef
24.
go back to reference Ferrara N (1995) The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36(2):127–137PubMedCrossRef Ferrara N (1995) The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36(2):127–137PubMedCrossRef
25.
go back to reference Bikfalvi A, Klein S, Pintucci G, Rifkin DB (1997) Biological roles of fibroblast growth factor-2. Endocr Rev 18(1):26–45PubMedCrossRef Bikfalvi A, Klein S, Pintucci G, Rifkin DB (1997) Biological roles of fibroblast growth factor-2. Endocr Rev 18(1):26–45PubMedCrossRef
26.
go back to reference Padro M, Mejias-Luque R, Cobler L, Garrido M, Perez-Garay M, Puig S, Peracaula R, de Bolos C (2011) Regulation of glycosyltransferases and Lewis antigens expression by IL-1beta and IL-6 in human gastric cancer cells. Glycoconj J 28(2):99–110. doi:10.1007/s10719-011-9327-4 PubMedCrossRef Padro M, Mejias-Luque R, Cobler L, Garrido M, Perez-Garay M, Puig S, Peracaula R, de Bolos C (2011) Regulation of glycosyltransferases and Lewis antigens expression by IL-1beta and IL-6 in human gastric cancer cells. Glycoconj J 28(2):99–110. doi:10.​1007/​s10719-011-9327-4 PubMedCrossRef
27.
go back to reference Nakamura H, Jasper MJ, Hull ML, Aplin JD, Robertson SA (2011) Macrophages regulate expression of alpha1,2 fucosyltransferase genes in human endometrial epithelial cells. Mol Hum Reprod. doi:10.1093/molehr/gar070 PubMed Nakamura H, Jasper MJ, Hull ML, Aplin JD, Robertson SA (2011) Macrophages regulate expression of alpha1,2 fucosyltransferase genes in human endometrial epithelial cells. Mol Hum Reprod. doi:10.​1093/​molehr/​gar070 PubMed
28.
go back to reference Wagers AJ, Kansas GS (2000) Potent induction of alpha(1,3)-fucosyltransferase VII in activated CD4 + T cells by TGF-beta 1 through a p38 mitogen-activated protein kinase-dependent pathway. J Immunol 165(9):5011–5016PubMed Wagers AJ, Kansas GS (2000) Potent induction of alpha(1,3)-fucosyltransferase VII in activated CD4 + T cells by TGF-beta 1 through a p38 mitogen-activated protein kinase-dependent pathway. J Immunol 165(9):5011–5016PubMed
29.
go back to reference Schnyder-Candrian S, Borsig L, Moser R, Berger EG (2000) Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells. Proc Natl Acad Sci U S A 97(15):8369–8374PubMedCrossRef Schnyder-Candrian S, Borsig L, Moser R, Berger EG (2000) Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells. Proc Natl Acad Sci U S A 97(15):8369–8374PubMedCrossRef
31.
go back to reference Labarriere N, Piau JP, Otry C, Denis M, Lustenberger P, Meflah K, Le Pendu J (1994) H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54(23):6275–6281PubMed Labarriere N, Piau JP, Otry C, Denis M, Lustenberger P, Meflah K, Le Pendu J (1994) H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54(23):6275–6281PubMed
32.
33.
go back to reference Rusnati M, Presta M (2007) Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. Curr Pharm Des 13(20):2025–2044PubMedCrossRef Rusnati M, Presta M (2007) Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. Curr Pharm Des 13(20):2025–2044PubMedCrossRef
35.
go back to reference Korc M, Friesel RE (2009) The role of fibroblast growth factors in tumor growth. Curr Cancer Drug Targets 9(5):639–651PubMedCrossRef Korc M, Friesel RE (2009) The role of fibroblast growth factors in tumor growth. Curr Cancer Drug Targets 9(5):639–651PubMedCrossRef
36.
go back to reference Hatch NE, Hudson M, Seto ML, Cunningham ML, Bothwell M (2006) Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F. J Biol Chem 281(37):27292–27305. doi:10.1074/jbc.M600448200 PubMedCrossRef Hatch NE, Hudson M, Seto ML, Cunningham ML, Bothwell M (2006) Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F. J Biol Chem 281(37):27292–27305. doi:10.​1074/​jbc.​M600448200 PubMedCrossRef
37.
go back to reference Zhao Y, Itoh S, Wang X, Isaji T, Miyoshi E, Kariya Y, Miyazaki K, Kawasaki N, Taniguchi N, Gu J (2006) Deletion of core fucosylation on alpha3beta1 integrin down-regulates its functions. J Biol Chem 281(50):38343–38350. doi:10.1074/jbc.M608764200 PubMedCrossRef Zhao Y, Itoh S, Wang X, Isaji T, Miyoshi E, Kariya Y, Miyazaki K, Kawasaki N, Taniguchi N, Gu J (2006) Deletion of core fucosylation on alpha3beta1 integrin down-regulates its functions. J Biol Chem 281(50):38343–38350. doi:10.​1074/​jbc.​M608764200 PubMedCrossRef
38.
39.
go back to reference Wang X, Fukuda T, Li W, Gao CX, Kondo A, Matsumoto A, Miyoshi E, Taniguchi N, Gu J (2009) Requirement of Fut8 for the expression of vascular endothelial growth factor receptor-2: a new mechanism for the emphysema-like changes observed in Fut8-deficient mice. J Biochem 145(5):643–651. doi:10.1093/jb/mvp022 PubMedCrossRef Wang X, Fukuda T, Li W, Gao CX, Kondo A, Matsumoto A, Miyoshi E, Taniguchi N, Gu J (2009) Requirement of Fut8 for the expression of vascular endothelial growth factor receptor-2: a new mechanism for the emphysema-like changes observed in Fut8-deficient mice. J Biochem 145(5):643–651. doi:10.​1093/​jb/​mvp022 PubMedCrossRef
41.
go back to reference Sone H, Kawakami Y, Sakauchi M, Nakamura Y, Takahashi A, Shimano H, Okuda Y, Segawa T, Suzuki H, Yamada N (2001) Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Biophys Res Commun 281(2):562–568PubMedCrossRef Sone H, Kawakami Y, Sakauchi M, Nakamura Y, Takahashi A, Shimano H, Okuda Y, Segawa T, Suzuki H, Yamada N (2001) Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Biophys Res Commun 281(2):562–568PubMedCrossRef
Metadata
Title
A novel role for inducible Fut2 in angiogenesis
Authors
Pei-Suen Tsou
Jeffrey H. Ruth
Phillip L. Campbell
Takeo Isozaki
SolHee Lee
Hubert Marotte
Steven E. Domino
Alisa E. Koch
Mohammad A. Amin
Publication date
01-01-2013
Publisher
Springer Netherlands
Published in
Angiogenesis / Issue 1/2013
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-012-9312-y

Other articles of this Issue 1/2013

Angiogenesis 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.